Fundraising Fox

Omri Amirav Drory

Investor

General Partner at NFX

San Francisco Bay Area

Writes $500K – $5M checks · typically $3M

FoundedImmuneBridgeLa Jolla LabsPepper BioResistanceBio · YCTalus Bio · YCTwoStep Therapeutics

About

Omri Amirav-Drory is a founder-operator with TechBio lifecycle experience—founding Genome Compiler (acquired by Twist Bioscience), serving as Twist VP of Corporate Development and Innovation and acting as CEO during incubation.

Invests in

AI & Machine LearningBiotechCrypto & Web3FintechMarketplaces

Experience

  1. EarthTraq CorporationBoard Membercurrent2026 — present
  2. PortalBoard Membercurrent2026 — present
  3. Cyclana BioBoard Membercurrent2025 — present
  4. ImmuneBridgeBoard Membercurrent2025 — present
  5. Powerhouse BiologyBoard Membercurrent2025 — present
  6. Permanence BioBoard Membercurrent2025 — present
  7. Radar TherapeuticsBoard Membercurrent2024 — presentSan Francisco Bay Area
  8. TwoStep TherapeuticsBoard Membercurrent2024 — presentSan Francisco Bay Area
  9. ZipBioBoard Membercurrent2023 — present
  10. CentivaxBoard Membercurrent2022 — present
  11. Renewal BioFounder & chairman of the boardcurrent2022 — presentRehovot, Center District, Israel
  12. PumpkinseedBoard Membercurrent2022 — present
  13. Talus BioBoard Membercurrent2021 — present
  14. Mana.bioBoard Membercurrent2021 — present
  15. Nanocarry TherapeuticsBoard Membercurrent2021 — present
  16. NFXGeneral Partnercurrent2020 — present
  17. Eleven TherapeuticsBoard Membercurrent2020 — present
  18. EdiTy TherapeuticsBoard Membercurrent2020 — present
  19. ImmunaiAdvisorcurrent2020 — present
  20. Light Bio, Inc.Board Membercurrent2020 — present

Education

  1. Stanford UniversityPostdoctoral, Biochemistry and Molecular Biology2007 — 2011
  2. Tel Aviv UniversityDoctor of Philosophy (Ph.D.), Biochemistry2003 — 2007
  3. Tel Aviv UniversityBachelor of Science - BS, Biochemistry and Molecular Biology2001 — 2003

Skills & more

Genomics79Lifesciences45Bioinformatics87Biochemistry41Molecular Biology77Biotechnology44Computational Biology29Genetics31Protein Chemistry29Protein Purification8Sequencing5Immunology6
+12 moreDNATechnology TransferPersonalized MedicineBiomedical EngineeringPCRCancerScientific WritingProtein ExpressionBiophysicsProteomicsDrug DiscoveryIn Vitro

From Omri's professional profile.

Same school

Shared employers

Deals · 5

TwoStep TherapeuticsBoard seat

via NFX · filed Jan 2026 · $62.2M raise

ImmuneBridgeBoard seat

via NFX · filed Apr 2025 · $7.1M raise

Talus BioBoard seat

via NFX · filed Aug 2024 · $11.3M raise

ResistanceBioBoard seat

via NFX · filed Jan 2024 · $12.8M raise

La Jolla LabsBoard seat

via NFX · filed Oct 2021 · $3.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at NFX

Network4

Investors connected to Omri in public investor directories — a warm-intro map.